Nov 26, 2020 / 12:00PM GMT
RenéC. Goehrum - BioSyent Inc. - Chairman, CEO & President
Hello, and welcome to the BioSyent Q3 2020 Results Presentation. My name is René Goehrum, and I'm the President and CEO of the company.
I'm going to start today's presentation with a look at our sales, EBITDA and net income after tax for the quarter ended September 30. So as you can see, our sales were just short of $5.8 million, and that was 7% below the year ago quarter. So that's made up of a couple of different elements that I just want to walk you through.
So our Canadian pharmaceutical business performed well. It was up 14% versus the year ago quarter. Our international pharmaceutical business, which is essentially selling FeraMAX oral iron supplement to customers outside of Canada, was down dramatically, down 99%.
So there's a couple of things that work there. One is that we are having some challenges in our largest market with that product, COVID related, and I'll speak to that in a couple of slides. The other is that in that quarter, the year ago quarter, our comp quarter was an
Q3 2020 Biosyent Inc Earnings Call Transcript
Nov 26, 2020
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers